LINK:  https://bswhealth.webex.com/bswhealth/j.php?MTID=m2e514c94c5fe5e877f72029385ac9d70

OBJECTIVES: Upon completion of this activity, the participant should be able to:  : (1) Analyze the importance of timely diagnosis and treatment of late acute T cell-mediated rejection. (2) Review central role of liver pathology in the diagnosis and management of rejection and the need for close collaboration between clinician and pathologist. (3) Explain what is known about acute and chronic antibody-mediated rejection post-liver transplant.

FACULTY DISCLOSURE: Thomas Schiano, MD, is a site Principal Investigator for Transplant Genomics, Inc.

PLANNER DISCLOSURE: James Trotter, MD, Sumeet Asrani, MD, Gregory McKenna, MD, and Kathy Brown, RN, CCTC, have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CEPTC Credit: The American Board for Transplant Certification (ABTC) has been applied for educational offering for up to 1 Category 1 Continuing Education Point for Transplant Certification (CEPTCs).

For information, please contact Karina Pena at karina.pena@bswhealth.org